Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06488157 · ClinicalTrials.gov registry record · NA

Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD

A NA study of Caregiver Burden, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06488157 is a NA study of Caregiver Burden that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 15 participants, below the 244-participant average among 41 other Caregiver Burden trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06488157, a NA study of Caregiver Burden, has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility and acceptability.

Conditions Studied

Interventions

  • OTHER I-HoME

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2024-07-10
Est. Completion 2025-05-23
Phase NA

What the Registry Record Tells You About NCT06488157

The ClinicalTrials.gov registry entry for NCT06488157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 244-participant average among 41 other Caregiver Burden trials with a reported enrollment target (94% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Caregiver Burden appearing as the primary indexed condition, and to 1 intervention - of which I-HoME is the first listed.

NCT06488157 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06488157 about?

NCT06488157 is a clinical study titled "Adapting and Implementing the I-HoME Intervention in Caregivers of Patients With ADRD". The purpose of this study is to pilot test the adapted Improving Home hospice Management of End-of-life issues through technology (I-HoME) intervention with family caregivers of patients with advanced Alzheimer's Disease and related dementia. Data will be collected regarding intervention feasibility...

What is the current status of trial NCT06488157?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2024-07-10. Estimated completion is 2025-05-23.

What conditions does trial NCT06488157 study?

This clinical trial studies the following conditions: Caregiver Burden.

What interventions are being tested in trial NCT06488157?

The interventions under investigation include: I-HoME (OTHER).

Who is sponsoring clinical trial NCT06488157?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06488157 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Caregiver Burden

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.